Exome sequencing revealed DNA variants in NCOR1, IGF2BP1, SGLT2 and NEK11 as potential novel causes of ketotic hypoglycemia in children

• Published in: Scientific reports Vol. 10; no. 1; p. 2114
• Main Authors: Alhaidan, Yazeid, Larsen, Martin J., Schou, Anders Jørgen, Stenlid, Maria H., Al Balwi, Mohammed A., Christesen, Henrik Thybo, Brusgaard, Klaus
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 07.02.2020; Nature Publishing Group
• Subjects: 45; 45/47; 692/308/2056; 692/308/3187; 692/53/2421; 692/699/2743/2037; 692/699/317; Bioinformatics; Blood Glucose - genetics; Child, Preschool; Children; Deoxyribonucleic acid; DNA; DNA sequencing; Exome - genetics; Female; Genetic Variation - genetics; Gluconeogenesis; Gluconeogenesis - genetics; Glucose transport; Humanities and Social Sciences; Humans; Hypoglycemia; Hypoglycemia - genetics; Infant; Iron deficiency; Ketosis - genetics; Male; Metabolism; multidisciplinary; NIMA-Related Kinases - genetics; Nuclear Receptor Co-Repressor 1 - genetics; Nutrient deficiency; Phenotyping; Precision medicine; RNA-Binding Proteins - genetics; Science; Science (multidisciplinary); Sodium-Glucose Transporter 2 - genetics
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-58845-3

Unexplained or idiopathic ketotic hypoglycemia (KH) is the most common type of hypoglycemia in children. The diagnosis is based on the exclusion of routine hormonal and metabolic causes of hypoglycemia. We aimed to identify novel genes that cause KH, as this may lead to a more targeted treatment. Deep phenotyping of ten preschool age at onset KH patients (boys, n = 5; girls, n = 5) was performed followed by trio exome sequencing and comprehensive bioinformatics analysis. Data analysis revealed four novel candidate genes: (1) NCOR1 in a patient with KH, iron deficiency and loose stools; (2) IGF2BP1 in a proband with KH, short stature and delayed bone age; (3) SLC5A2 in a proband with KH, intermittent glucosuria and extremely elevated p-GLP-1; and (4) NEK11 in a proband with ketotic hypoglycemia and liver affliction. These genes are associated with different metabolic processes, such as gluconeogenesis, translational regulation, and glucose transport. In conclusion, WES identified DNA variants in four different genes as potential novel causes of IKH, suggesting that IKH is a heterogeneous disorder that can be split into several novel diseases: NCOR1-KH, IGF2BP1-KH, SGLT2-KH or familial renal glucosuria KH, and NEK11-KH. Precision medicine treatment based on exome sequencing may lead to advances in the management of IKH.